Literature DB >> 25414378

Trade secrets in life science and pharmaceutical companies.

Tara Nealey1, Ronald M Daignault1, Yu Cai1.   

Abstract

Trade secret protection arises under state common law and state statutes. In general, a trade secret is information that is not generally known to the public and is maintained as a secret, and it provides a competitive advantage or economic benefit to the trade secret holder. Trade secrets can be worth tens or hundreds of millions of dollars, and damage awards in trade secret litigation have been high; often, there is a lot at stake. Obtaining a trade secret through "improper means" is misappropriation. If the alleged trade secret, however, was developed independently, known publicly, or not maintained as a secret, then those defenses may successfully overcome a claim for trade secret misappropriation. With today's interconnectedness in the biotechnology and pharmaceutical fields, more collaborations, joint ventures, and outsourcing arrangements among firms, and increased mobility of employees' careers, life science companies need to not only understand how to protect their trade secrets, but also know how to defend against a claim for trade secret theft.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Mesh:

Year:  2014        PMID: 25414378      PMCID: PMC4382727          DOI: 10.1101/cshperspect.a020982

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  1 in total

1.  Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain-a model-based analysis.

Authors:  Jan Norum; Margareth Aarag Antonsen; Terje Tollåli; Khalid Al-Shibli; Gry Andersen; Kristin Helene Svanqvist; Nina Helbekkmo
Journal:  ESMO Open       Date:  2017-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.